FRI067 Efficacy And Safety Of Glucagon-like Peptide 1 Analogs And Agonists (aGLP1) In Overweight/Obese Patients: A Systematic Review And An Updated Network Meta-analysis

Disclosure: C.H. Silva: None. E. Mund: None. J. Watanabe: None. V. José: None. Y. Lorene: None. L. Lucena: None. J.G. Lima: None. Background: Obesity is a chronic disease related to mortality worldwide. aGLP1 are the more effective therapeutic class for weight loss. We aimed to evaluate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Caroliny Hellen, Mund, Eduardo, Watanabe, Janine, José, Victor, Lorene, Yasmin, Lucena, Larissa, Lima, Josivan G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553987/
http://dx.doi.org/10.1210/jendso/bvad114.077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553987/
http://dx.doi.org/10.1210/jendso/bvad114.077

Ejemplares similares